Cargando…

Anti-Lan Antibodies: A Rare Etiology of Severe Blood Transfusion Reaction

Lan is a high prevalence red blood cell antigen present in the majority of the populations that belong to the Lan (Langereis) blood group system. Anti-Lan antibody is an immunoglobulin G (IgG) antibody that is known to cause delayed hemolytic transfusion reactions in adults as well as hemolytic dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Purva, Manthri, Sukesh, Patterson, Emily, Youssef, Bahaaeldin, Chakraborty, Kanishka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647357/
https://www.ncbi.nlm.nih.gov/pubmed/33173638
http://dx.doi.org/10.7759/cureus.10832
_version_ 1783606896900440064
author Sharma, Purva
Manthri, Sukesh
Patterson, Emily
Youssef, Bahaaeldin
Chakraborty, Kanishka
author_facet Sharma, Purva
Manthri, Sukesh
Patterson, Emily
Youssef, Bahaaeldin
Chakraborty, Kanishka
author_sort Sharma, Purva
collection PubMed
description Lan is a high prevalence red blood cell antigen present in the majority of the populations that belong to the Lan (Langereis) blood group system. Anti-Lan antibody is an immunoglobulin G (IgG) antibody that is known to cause delayed hemolytic transfusion reactions in adults as well as hemolytic disease in fetuses and newborns, however with variable clinical significance ranging from mild to severe. We present a 58-year-old woman with diffuse abdominal pain and a large gastric ulcer causing gastric outlet obstruction. She underwent antrectomy and Billroth I reconstruction surgery without complications. The patient’s hemoglobin upon presentation was 10g/dL and dropped acutely post-operatively to 6.4 g/dL requiring blood transfusion. The patient developed acute respiratory distress within minutes of starting a packed red blood cell (pRBC) transfusion, requiring discontinuation. Laboratory testing demonstrated pan-reactivity with additional reference testing demonstrating an anti-Lan antibody. The rarity of Lan negative pRBC units is a challenge in managing such patients requiring blood transfusions. Autologous blood donation or donation by a compatible family member is another option to consider in these rare cases.
format Online
Article
Text
id pubmed-7647357
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-76473572020-11-09 Anti-Lan Antibodies: A Rare Etiology of Severe Blood Transfusion Reaction Sharma, Purva Manthri, Sukesh Patterson, Emily Youssef, Bahaaeldin Chakraborty, Kanishka Cureus Internal Medicine Lan is a high prevalence red blood cell antigen present in the majority of the populations that belong to the Lan (Langereis) blood group system. Anti-Lan antibody is an immunoglobulin G (IgG) antibody that is known to cause delayed hemolytic transfusion reactions in adults as well as hemolytic disease in fetuses and newborns, however with variable clinical significance ranging from mild to severe. We present a 58-year-old woman with diffuse abdominal pain and a large gastric ulcer causing gastric outlet obstruction. She underwent antrectomy and Billroth I reconstruction surgery without complications. The patient’s hemoglobin upon presentation was 10g/dL and dropped acutely post-operatively to 6.4 g/dL requiring blood transfusion. The patient developed acute respiratory distress within minutes of starting a packed red blood cell (pRBC) transfusion, requiring discontinuation. Laboratory testing demonstrated pan-reactivity with additional reference testing demonstrating an anti-Lan antibody. The rarity of Lan negative pRBC units is a challenge in managing such patients requiring blood transfusions. Autologous blood donation or donation by a compatible family member is another option to consider in these rare cases. Cureus 2020-10-06 /pmc/articles/PMC7647357/ /pubmed/33173638 http://dx.doi.org/10.7759/cureus.10832 Text en Copyright © 2020, Sharma et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Sharma, Purva
Manthri, Sukesh
Patterson, Emily
Youssef, Bahaaeldin
Chakraborty, Kanishka
Anti-Lan Antibodies: A Rare Etiology of Severe Blood Transfusion Reaction
title Anti-Lan Antibodies: A Rare Etiology of Severe Blood Transfusion Reaction
title_full Anti-Lan Antibodies: A Rare Etiology of Severe Blood Transfusion Reaction
title_fullStr Anti-Lan Antibodies: A Rare Etiology of Severe Blood Transfusion Reaction
title_full_unstemmed Anti-Lan Antibodies: A Rare Etiology of Severe Blood Transfusion Reaction
title_short Anti-Lan Antibodies: A Rare Etiology of Severe Blood Transfusion Reaction
title_sort anti-lan antibodies: a rare etiology of severe blood transfusion reaction
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647357/
https://www.ncbi.nlm.nih.gov/pubmed/33173638
http://dx.doi.org/10.7759/cureus.10832
work_keys_str_mv AT sharmapurva antilanantibodiesarareetiologyofseverebloodtransfusionreaction
AT manthrisukesh antilanantibodiesarareetiologyofseverebloodtransfusionreaction
AT pattersonemily antilanantibodiesarareetiologyofseverebloodtransfusionreaction
AT youssefbahaaeldin antilanantibodiesarareetiologyofseverebloodtransfusionreaction
AT chakrabortykanishka antilanantibodiesarareetiologyofseverebloodtransfusionreaction